Novel Oral GLP-1 Agent Cuts A1c, Weight in Early Diabetes

By News Health
1 month Ago

(MedPage Today) — CHICAGO — An investigational, oral small-molecule GLP-1 receptor agonist improved glycated hemoglobin levels in adults with early-stage type 2 diabetes, a phase III randomized trial found.
Among 559 participants in ACHIEVE…

Source link : https://www.medpagetoday.com/meetingcoverage/ada/116186

Author :

Publish date : 2025-06-21 21:36:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

'Ozempic Teeth:' Another Effect of GLP-1 Agonists?

Yes, HCQ Does Help Preserve Renal Function in Lupus Nephritis

Pentagon Tightens Rules on Getting Medical Waivers to Join the Military

Multidrug Regimen Appears Feasible for Older Patients With Advanced Hodgkin Lymphoma

Cleaner air has increased the number of city heatwaves

CGM Receiver Recall; Interchangeable Novolog Biosimilar OK'd; Barbie With Diabetes